Acceder

Bibliografías temáticas / Immune response / Artículos de revistas

Siga este enlace para ver otros tipos de publicaciones sobre el tema: Immune response.

Artículos de revistas sobre el tema "Immune response"

Autor: Grafiati

Publicado: 4 de junio de 2021

Última modificación: 2 de noviembre de 2024

Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros

Elija tipo de fuente:

Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "Immune response".

Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.

También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.

Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.

1

A, Kavitha, Priavadhana Rajan Prasaad, Bheema Rao G y Hemalatha Ganapathy. "Immune Response in Tuberculosis - CD4/CD68 Epitope Mapping". Annals of Pathology and Laboratory Medicine 5, n.º 9 (14 de septiembre de 2018): A759–763. http://dx.doi.org/10.21276/apalm.1960.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

2

Pleskanovskaya, S. A. "ADАPTIVE TRANSFER OF THE IMMUNE RESPONSE – NEW APPROACHES". European Journal of Natural History, n.º 6 2020 (2020): 11–16. http://dx.doi.org/10.17513/ejnh.34134.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

3

GC, Velasquez Serra. "Monitoring of Immune Response Following Covid-19 Vaccination". Virology & Immunology Journal 7, n.º 1 (4 de enero de 2023): 1–9. http://dx.doi.org/10.23880/vij-16000311.

Texto completo

Resumen

Introduction: SARS-CoV-2 is an infectious, viral, and contagious disease in which most patients present a mild respiratory condition whose recovery is autonomous and guided by the immune system itself. Objectives: The objectives of this research were to evaluate the immune system, the vaccination doses administered to the inhabitants of the parish of El Recreo, located in the Duran Canton of the Province of Guayas (Ecuador), according to age groups and gender, the vaccination coverage and the incidence of new diseases in the population under study. Material and Methods: This was a descriptive, non-experimental, prospective, cross-sectional, field study. It was carried out during the period from November 2021 to March 2022, during the pandemic of the "Omicron" variant. Results: the predominant age group corresponded to the range of 50-59 years (26.83% and 42; 29.79%) for both genders. We found (90.10%) of the population vaccinated. Another group (3.31%) did not receive the biologic and (6.59%) indicated that they were reluctant to receive the product. The second dose was administered to (83.5%) people in the community, while (14.28%) indicated having received the third dose. (3.04%) became ill after receiving the first doses; (2.63%) the second doses and none of those who received the third doses. It is necessary to alert the population of the need to benefit from the application of the vaccine since it seems to confer a certain degree of protection to the inhabitants and thus, the viral spread, hospitalization and death.

Los estilos APA, Harvard, Vancouver, ISO, etc.

4

Batchelor, J. R. "Immune response". Nature 337, n.º 6204 (enero de 1989): 220. http://dx.doi.org/10.1038/337220a0.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

5

Malinova, Dessi. "Immune response". Opticon1826 7, n.º 12 (30 de abril de 2012): 22. http://dx.doi.org/10.5334/opt.121214.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

6

Pearson, Steven D. "Immune Response". JAMA: The Journal of the American Medical Association 256, n.º 22 (12 de diciembre de 1986): 3088. http://dx.doi.org/10.1001/jama.1986.03380220054009.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

7

Jamieson, Amanda Mercedes, Meredith Crane, Yun Xu y Kayla Lee. "Immune triage: prioritization of host immune responses." Journal of Immunology 196, n.º 1_Supplement (1 de mayo de 2016): 197.20. http://dx.doi.org/10.4049/jimmunol.196.supp.197.20.

Texto completo

Resumen

Abstract The immune response is important in many functions, including host defense against pathogens, wound healing, development, response to cancer, and maintenance of homeostatic physiological responses. We are interested in the concept of immune triage, in that a given host must be able to deal effectively with multiple insults, and at times prioritize immune responses. It is important for the overall health status of the host that the immune system responds effectively to protect essential organs. We have developed several mouse models, focusing on the lung immune response, that allow us to examine different aspects of immune triage. The lung is an essential and delicate organ and thus pulmonary immune responses must be tightly regulated. We have determined that lung infection with influenza A virus (IAV) alters the response to bacterial lung infections. Depending on the bacterial infection, previous infection with IAV can suppress or augment the immune response to bacteria. We have also determined that pulmonary infection with IAV alters many aspects of the systemic immune response. There is a global suppression to systemic bacterial infection, and a decrease in the wound healing response. Our data indicate that the immune system prioritizes lung infections over many other responses. This is most likely due to the importance of the lung in host survival. We have established several regulatory mechanisms by which this immune triage occurs. By understanding how the immune system responds to multiple insults we can improve our understanding of the immune network on a global level.

Los estilos APA, Harvard, Vancouver, ISO, etc.

8

Kannan, Rajni, Kathleen Madden y Stephanie Andrews. "Primer on Immuno-Oncology and Immune Response". Clinical Journal of Oncology Nursing 18, n.º 3 (27 de mayo de 2014): 311–17. http://dx.doi.org/10.1188/14.cjon.311-317.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

9

AK, Vyas. "The Muddle of Immune Response in Coronavirus Disease-19". Open Access Journal of Microbiology & Biotechnology 5, n.º 3 (2020): 1–3. http://dx.doi.org/10.23880/oajmb-16000171.

Texto completo

Resumen

Coronavirus Disease-19 (COVID19) caused by the enormously spreadable SARS- CoV-2 virus has appeared as a global pandemic and leads to high mortalities. Approximately 31,243,339 people have been infected so far with this disease which has led to the death of more than 965,103patients as of 21st Sept 2020. There are many drug molecules under-trials are in phase I and II. The numerous possible candidates for vaccine development against this infectious virus are also in the pipeline. Although, so far no molecule as a therapeutics or vaccine for prevention has been approved. Recent reports have observed that severely ill patients have a differential immunological profile compared to mild COVID-19 infection. Current studies globally observed that the cytokine storm maybe leads to the severity of COVID19 infection. In this article, our focus is to describe the present knowledge and status of differential immune profile among patients infected with COVID19 infection and their association with disease progression mild to severe.

Los estilos APA, Harvard, Vancouver, ISO, etc.

10

Joob, Beuy y Viroj Wiwanitkit. "Neurocysticercosis, immune status and immune response". Arquivos de Neuro-Psiquiatria 70, n.º 9 (septiembre de 2012): 750. http://dx.doi.org/10.1590/s0004-282x2012000900023.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

11

Eichner, E. Randy. "Immune Response Question". Physician and Sportsmedicine 27, n.º 9 (septiembre de 1999): 83. http://dx.doi.org/10.3810/psm.1999.09.1005.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

12

Sarfati, Marika y Guy Delespesse. "Fetal Immune Response". Science 273, n.º 5276 (9 de agosto de 1996): 722–23. http://dx.doi.org/10.1126/science.273.5276.722.b.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

13

Sarfati, Marika y Guy Delespesse. "Fetal Immune Response". Science 273, n.º 5276 (9 de agosto de 1996): 722–23. http://dx.doi.org/10.1126/science.273.5276.722-b.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

14

Sarfati, M. y G. Delespesse. "Fetal Immune Response". Science 273, n.º 5276 (9 de agosto de 1996): 721d—725. http://dx.doi.org/10.1126/science.273.5276.721d.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

15

Sarfati, M. y G. Delespesse. "Fetal Immune Response". Science 273, n.º 5276 (9 de agosto de 1996): 722b—723b. http://dx.doi.org/10.1126/science.273.5276.722b.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

16

Hurtley, S. M. "Immune Response Regulation". Science's STKE 2006, n.º 358 (17 de octubre de 2006): tw366. http://dx.doi.org/10.1126/stke.3582006tw366.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

17

De Moreno De Leblanc, A., J. Valdéz y G. Perdigón. "Inflammatory Immune Response". European Journal of Inflammation 2, n.º 1 (enero de 2004): 21–31. http://dx.doi.org/10.1177/1721727x0400200104.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

18

Mak, Tak W. y Mary E. Saunders. "THE IMMUNE RESPONSE". Shock 27, n.º 2 (febrero de 2007): 220–21. http://dx.doi.org/10.1097/01.shk.0000258367.85587.7b.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

19

Baldwin, Cynthia L. "Immune response overview". Veterinary Microbiology 90, n.º 1-4 (diciembre de 2002): 365–66. http://dx.doi.org/10.1016/s0378-1135(02)00221-3.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

20

Burroughs, N. J., B. M. P. M. Oliveira, A. A. Pinto y M. Ferreira. "Immune response dynamics". Mathematical and Computer Modelling 53, n.º 7-8 (abril de 2011): 1410–19. http://dx.doi.org/10.1016/j.mcm.2010.02.040.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

21

Phelps, Jerry. "Headliners: Immune Response". Environmental Health Perspectives 111, n.º 10 (1 de agosto de 2003): a521. http://dx.doi.org/10.1289/ehp.111-a521.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

22

Lydyard, P. M. "Immune response overview". Current Opinion in Immunology 1, n.º 2 (diciembre de 1988): 201–2. http://dx.doi.org/10.1016/0952-7915(88)90001-5.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

23

Arthur Blair, Eric. "Immune deficiency derive a favorable response to IVIg in PANDAS". Psychology and Mental Health Care 2, n.º 3 (6 de julio de 2018): 01–03. http://dx.doi.org/10.31579/2637-8892/032.

Texto completo

Resumen

For two decades, pediatric autoimmune neuropsychiatric disorder associated with group a beta hemolytic streptococcal infection (PANDAS) has been treated with high-dose intravenous immune globulin (IVIg) therapy based upon the understanding that the disorder is partly due to post-infectious dysimmunity.

Los estilos APA, Harvard, Vancouver, ISO, etc.

24

Skok, M. V. "Proposals for the ISS: «Immunity» Experiment Immune response in microgravity". Kosmìčna nauka ì tehnologìâ 6, n.º 4 (30 de julio de 2000): 103. http://dx.doi.org/10.15407/knit2000.04.107.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

25

Barton, B. E. y D. A. Levy. "The Immune Response to a Schistosomacide, Amoscanate Ii. Cell-Mediated Immune Responses". Journal of Immunopharmacology 7, n.º 3 (enero de 1985): 373–83. http://dx.doi.org/10.3109/08923978509026482.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

26

Hamadou, Takieddine, Imene Hamadou, Ahmed Menad, Somia Bouameur y Souad Ameddah. "COVID-19 : histoire, pathogenèse et réponse immunitaire de l'hôte". Batna Journal of Medical Sciences (BJMS) 8, n.º 1 (4 de junio de 2021): 52–58. http://dx.doi.org/10.48087/bjmsra.2021.8110.

Texto completo

Resumen

By the end of 2019, pneumonia of unknown etiology occurred in Wuhan, China. Local hospitals started receiving patients presenting symptoms like dry cough, fatigue, and breathing difficulties, most of these patients were linked to the Huanan seafood market, Wuhan, China. The pandemic was afterward confirmed to be associated with a novel coronavirus. The virus spread quickly from Wuhan to other provinces of China, then from china to the rest of the world causing thereby one of the most brutal pandemics in the world’s history. SARS-CoV2 has a long incubation period ranging from 3 to 7 days and can go up to 14 days in some cases which makes the infection difficult to be detected early and subsequently the disease spread harder to be controlled. SARS-CoV-2 is a single-stranded RNA virus with 4 main structural proteins, the spike (S) glycoprotein, the small envelope (E) the glycoprotein, the membrane (M) glycoprotein as well as the nucleocapsid (N) protein. Current knowledge about the virus shows that it uses its spike protein to invade host cells, mainly the alveolar epithelial cells. The the lung is the most targeted organ among many other organs like the heart, small intestine, and kidneys that are vulnerable to SARS-CoV-2 infection. The COVID-19 is known to be mild in most cases, but in some cases, it can be severe or even fatal. In the severe cases, acute respiratory distress syndrome was reported, and the the capability of SARS-CoV-2 to infect many organs can lead to multiorgan failure and death. SARS-CoV-2 invasion induces several immune responses that could be efficient for infection clearance in mild cases, while in severe cases, the immune response dysfunctions can even contribute to the disease aggravation. Neither the the pathogenic mechanism by which SARS-CoV-2 infects host cells, nor the host immune response to its infection have been fully understood, hence further studies are needed to give further evidence about these two phenomena. Keywords: COVID-19, SARS-CoV-2, Coronavirus, Structural proteins, Immune response.

Los estilos APA, Harvard, Vancouver, ISO, etc.

27

Sekenova, A. y V. Ogay. "Role of mesenchymal stem cells in the regulation of immune response". BULLETIN of the L.N. Gumilyov Eurasian National University. BIOSCIENCE Series 123, n.º 2 (2018): 69–83. http://dx.doi.org/10.32523/2616-7034-2018-123-2-69-83.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

28

Thabit, Sandford. "Current Studies of Immunotherapy for glioblastoma triggers a measurable immune response". Psychology and Mental Health Care 2, n.º 3 (1 de julio de 2018): 01–06. http://dx.doi.org/10.31579/2637-8892/029.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

29

Dimayuga, Paul C., Kuang-Yuh Chyu y Bojan Cercek. "Immune responses regulating the response to vascular injury". Current Opinion in Lipidology 21, n.º 5 (octubre de 2010): 416–21. http://dx.doi.org/10.1097/mol.0b013e32833cacbe.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

30

Hartman, Zachary, Xiao Yi Yang, Gangjun Lei, Andrea Amalfitano, Michael Morse, Herbert Kim Lyerly y Tim Clay. "Modulation of adenoviral vector immune responses through the over-expression of immune adaptor and viral immuno-modulatory genes (48.17)". Journal of Immunology 178, n.º 1_Supplement (1 de abril de 2007): S77—S78. http://dx.doi.org/10.4049/jimmunol.178.supp.48.17.

Texto completo

Resumen

Abstract For the past two decades, adenoviral vector platforms have been used as both gene therapy vehicles and vaccine platforms in various human clinical trials. However, the use of these, as well as other viral vector platforms, has been tempered by the innate immune and adaptive immune responses elicited. Despite the development of advanced generation adenoviral vectors, the innate responses precipitated by these vectors have remained largely unchanged due to the particular nature of the viral capsid and infectious process. To more effectively use these vectors for different purposes, we constructed adenoviral vectors encoding overexpression cassettes for various TLR adaptors (MyD88 and TRIF), RIG-I pathway adaptor (MAVS), as well as immuno-modulatory viral genes (pp65) whose expression might accentuate or inhibit the innate immune response enabled by adenoviral infection. Our studies show that while all of these immuno-modulatory vectors were able to effectively enhance (TLR and MAVS vectors) or inhibit (pp65 vectors) the NF-kB and IFN-beta responses in vitro, only certain vectors were able to affect the adaptive responses elicited in vivo. While our findings show that vector manipulation can influence vector-specific innate and adaptive immune responses, they also offer evidence for the highly regulatory nature of the innate response, as evidenced by the limited impact of certain adaptor overexpression.

Los estilos APA, Harvard, Vancouver, ISO, etc.

31

Haig, David M., Jackie Thomson, Colin McInnes, Catherine McCaughan, Wendy Imlach, Andrew Mercer y Stephen Fleming. "Orf virus immuno-modulation and the host immune response". Veterinary Immunology and Immunopathology 87, n.º 3-4 (septiembre de 2002): 395–99. http://dx.doi.org/10.1016/s0165-2427(02)00087-9.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

32

Walczak, Aleksandra M. "Response in Immune Repertoires". Biophysical Journal 120, n.º 3 (febrero de 2021): 194a—195a. http://dx.doi.org/10.1016/j.bpj.2020.11.1338.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

33

Dean, Dwane H., Raymond N. Hiramoto y Vithal K. Ghanta. "Modulation of Immune Response". Journal of Periodontology 58, n.º 7 (julio de 1987): 498–500. http://dx.doi.org/10.1902/jop.1987.58.7.498.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

34

Suarez, Giovanni. "Immune response toH pylori". World Journal of Gastroenterology 12, n.º 35 (2006): 5593. http://dx.doi.org/10.3748/wjg.v12.i35.5593.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

35

&NA;. "HIV Vaccine ??? Immune Response". Drugs in R & D 3, n.º 6 (2002): 411–20. http://dx.doi.org/10.2165/00126839-200203060-00011.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

36

Vignieri, Sacha. "Reconfiguring an immune response". Science 369, n.º 6511 (24 de septiembre de 2020): 1579.1–1579. http://dx.doi.org/10.1126/science.369.6511.1579-a.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

37

Koga, Tetsuya. "Immune Response in Dermatophytosis". Nippon Ishinkin Gakkai Zasshi 44, n.º 4 (2003): 273–75. http://dx.doi.org/10.3314/jjmm.44.273.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

38

del Mar Casal, Maria y Manuel Casal. "Immune Response to Mycobacteria". Current Immunology Reviews 7, n.º 1 (1 de febrero de 2011): 13–18. http://dx.doi.org/10.2174/157339511794474280.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

39

Iwaguchi, Takao y Tadayoshi Matsuda. "Hyperthermia and Immune Response". Thermal Medicine(Japanese Journal of Hyperthermic Oncology) 6, n.º 1 (1990): 19–28. http://dx.doi.org/10.3191/thermalmedicine.6.19.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

40

Sander, Ruth. "Exercise boosts immune response". Nursing Older People 24, n.º 6 (29 de junio de 2012): 11. http://dx.doi.org/10.7748/nop.24.6.11.s11.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

41

Novikova, I. A. "IRON AND IMMUNE RESPONSE". Health and Ecology Issues, n.º 4 (28 de diciembre de 2011): 42–48. http://dx.doi.org/10.51523/2708-6011.2011-8-4-7.

Texto completo

Resumen

The present-day data on possible pathways of iron influence on human immune response and susceptibility to infections have been considered. The article describes changes of immunologic resistance in conditions of low iron level and mechanisms of iron status disturbance as a consequence of immunostimulation.

Los estilos APA, Harvard, Vancouver, ISO, etc.

42

Siu, Venus WS. "Sepsis and immune response". World Journal of Emergency Medicine 2, n.º 2 (2011): 99. http://dx.doi.org/10.5847/wjem.j.issn.1920-8642.2011.02.004.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

43

Cai, Xiao-fang. "Sepsis and immune response". World Journal of Emergency Medicine 2, n.º 2 (2011): 117. http://dx.doi.org/10.5847/wjem.j.issn.1920-8642.2011.02.007.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

44

Ren, Hong-sheng. "Sepsis and immune response". World Journal of Emergency Medicine 2, n.º 2 (2011): 127. http://dx.doi.org/10.5847/wjem.j.issn.1920-8642.2011.02.009.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

45

&NA;. "Zidovudine lowers immune response?" Inpharma Weekly &NA;, n.º 887 (mayo de 1993): 7. http://dx.doi.org/10.2165/00128413-199308870-00013.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

46

Akilov, OE y KY Mumcuoglu. "Immune response in demodicosis". Journal of the European Academy of Dermatology and Venereology 18, n.º 4 (julio de 2004): 440–44. http://dx.doi.org/10.1111/j.1468-3083.2004.00964.x.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

47

Han, Jae Pil y Su Jin Hong. "Immune Response toHelicobacter pyloriInfection". Korean Journal of Helicobacter and Upper Gastrointestinal Research 13, n.º 4 (2013): 220. http://dx.doi.org/10.7704/kjhugr.2013.13.4.220.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

48

Sedwick, Caitlin. "Imaging the immune response". Journal of Cell Biology 179, n.º 3 (22 de octubre de 2007): 362. http://dx.doi.org/10.1083/jcb.1793rr1.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

49

&NA;, &NA;. "Pathogenesis and immune response". Current Opinion in Infectious Diseases 5, n.º 3 (junio de 1992): 469–84. http://dx.doi.org/10.1097/00001432-199206000-00025.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

50

&NA;, &NA;. "Pathogenesis and immune response". Current Opinion in Infectious Diseases 8, n.º 3 (junio de 1995): B87. http://dx.doi.org/10.1097/00001432-199506000-00016.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

Ofrecemos descuentos en todos los planes premium para autores cuyas obras están incluidas en selecciones literarias temáticas. ¡Contáctenos para obtener un código promocional único!